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Introduction
Gangliosides and globosides are classes of glycosphingolipids
synthesized from lactosylceramide in the middle and late
Golgi. They can serve receptor functions in the plasma
membranes of many different cell types. The ganglioside GM1
can act as a receptor for the B subunits of various AB5 toxins
like Cholera toxin (CTX) or the heat-stable toxin II from
Escherichia coli (Van Heyningen, 1974; King and Van
Heyningen, 1974; Holmgren et al., 1973; Holmgren et al.,
1985; Griffiths et al., 1986; Spangler, 1992) whereas the
globotriaoside Gb3 is a receptor for the AB5-toxin Shiga toxin
(ST) and some related toxins like Verotoxin (Lindberg et al.,
1987; Lingwood et al., 1987). Application of gangliosides or
globosides to cells can elicit cellular responses as divergent as
signal transduction, cell adhesion or cell growth (Hakomori
and Igarashi, 1993). Moreover, the expression of these
glycosphingolipids on the surface of the plasma membrane
shows strong variations depending on the cell type and the state
of the cell.
Cell differentiation affects synthesis and plasma membrane
expression of Gb3. Undifferentiated THP-1 cells express
significantly more Gb3 on their surface than differentiated cells
(Ramegowda et al., 1996), while the situation is opposite in
intestinal epithelial cells where differentiated cells express high
levels of Gb3 on their surface and undifferentiated cells show an
almost complete loss of Gb3 (Jacewicz et al., 1975). In some
cells the expression of Gb3 on the cell surface seems to be
developmentally regulated. In rabbit intestinal microvilli
epithelial cells, the synthesis of Gb3 increases during the third
week of life together with an increased sensitivity to the toxic
effects of ST (Mobassaleh et al., 1994). The cellular level of
gangliosides also seems to be regulated by differentiation. It
decreases in 3T3-L1-adipocytes as they become differentiated.
In particular, the level of GM1 drops by 75-80%. These changes
could not be observed in the non-differentiating 3T3-C2 cell line
(Reed et al., 1980). In colon carcinoma cells (Nojiri et al., 1999)
as well as in renal carcinoma cells (Saito et al., 2000), the
synthesis of ganglioside GM3, a precursor of GM1, increases
following induction of differentiation. The percentage of
cultivated MFII-fibroblasts exhibiting high levels of GM3
increases as cells become confluent (Rosner et al., 1990). A
similar observation has been made with cultivated Zejdela
hepatoma cells (Staedel-Flaig et al., 1987). Interestingly,
treatment of a variety of different cell types with butyrate induces
synthesis and cell surface expression of GM1 as well as of Gb3
(Fishman and Attikan, 1979), leading to an enhanced binding of
CTX as well as of ST and verotoxin. Choi et al. (Choi et al.,
1997) have studied the levels of neutral and acidic gangliosides
in different phases of the cell cycle in a glioma cell line. Cell-
cycle-dependent changes, in particular of GM3, GM2 and GM1,
could not be observed, although a decrease in b-series
gangliosides was measured during metaphase. 
We report here that Vero cells, a green monkey kidney tumor
cell line, show cell-cycle-dependent but inverse changes in
surface-expressed GM1 and Gb3. During interphase and G1,
cells bind almost exclusively CTX; during S-phase binding of
both CTX and ST is very low. During G2, binding of ST
increases and remains high during metaphase and telophase,
whereas the binding of CTX remains low until G0/G1 is
reached again. The cell-cycle-dependent changes in the
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Cholera and Shiga toxin bind to the cell surface via
glycolipid receptors GM1 and Gb3, respectively.
Surprisingly, the majority of Vero cells from a non-
synchronized population bind either Cholera or Shiga
toxin but not both toxins. The hypothesis that the
differential expression of toxin receptors is regulated by the
cell cycle was tested. We find that Cholera toxin binds
preferentially in G0/G1, with little binding through S-phase
to telophase, whereas Shiga toxin binds maximally through
G2 to telophase but does not bind during G0/G1 and
S-phase. The changes result from the corresponding
changes in Gb3 and GM1 synthesis, not from variations of
receptor transport to the cell surface. The changes do not
reflect competition of Gb3 and GM1 synthesis for
lactosylceramide. Cells as diverse as Vero cells, PC12 cells
and astrocytes show the same cell-cycle-dependent
regulation of glycosphingolipid receptors, suggesting that
this novel phenomenon is based on a conserved regulatory
mechanism.
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expression of GM1 and Gb3 on the cell surface result from
corresponding changes of synthesis of GM1 and Gb3,
respectively. These observations were confirmed also for other
cell types including Vero 317 cells, undifferentiated and
differentiated PC12 cells and astrocytes, suggesting that a
conserved mechanism is underlying this novel phenomenon.
Materials and Methods 
Cells
Vero and Vero 317 cells were obtained from ATCC. PC12 cells, a rat
chromaffin tumor cell line, was a kind gift of Dieter Bruns, this
laboratory.
Toxins and antibodies
CTX-K63 (kindly donated by Mariagrazia Pizza, Siena, Italy) was
used throughout the experiments. CTX-K63 has a S63K-mutation in
the CTX-A subunit that completely abolishes its ADP-ribosylating
activity (Fontana et al., 2000) without affecting its intracellular
transport (Majoul et al., 1998). ST was isolated as described
previously (Kozlov et al., 1993) (from the Engelhardt Institute of
Molecular Biology, Moscow). Both toxins were directly labeled with
Cy3- or Cy5-monosuccinimidyl esters or with Cy2-bissucccinimidyl
ester according to the Amersham Pharmacia Biotech protocol.
Labeled proteins were separated from free chromophores by gel
filtration over G-10 and concentrated by Centricon-10 (AmiconTM)
centrifugation. The labeling stoichiometry was determined from the
absorptions at 280 nm (protein), 487 nm (Cy2), 550 nm (Cy3), or
650 nm (Cy5). The molar dye:protein ratios ranged from 0.2 to 1. A
polyclonal rabbit anti-cyclin B1 antibody and a mouse monoclonal
anti-BrdU-antibody came from Transduction Laboratories (BD
Biosciences, Heidelberg, Germany), and a FITC-conjugated mouse
monoclonal anti-BrdU-antibody was from Pharmingen (BD
Biosciences, Heidelberg, Germany). Mouse monoclonal anti-cyclin
B1 antibodies were a kind gift of Jonathan Pines (CRC, Cambridge,
UK). A horseradish-peroxidase-conjugated goat anti-rabbit antibody
was from Zymed Laboratories (San Francisco, USA).
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Fig. 1. Differential binding of Shiga anCd cholera toxin to Vero cells;
differences in gene expression in Shiga versus Cholera toxin binding
Vero cells. (a) Differential binding of Cy3-CTX (CTX-Cy3) and
Cy2-ST (ST-Cy2) to non-synchronized Vero cells. Cells were
incubated simultaneously with the two labeled toxins for 10 minutes
at 0°C. Unbound toxins were washed away and the live cells
observed by fluorescence microscopy. (b) Differential display
comparing ST binding cells (S) and CTX binding cells (C). Non-
synchonized Vero cells were labeled simultaneously with Cy2-ST
and Cy3-CTX as in (a) and separated by FACS. cDNA was
synthesized from RNA extracted from ST and CT binding cells.
DNA fragments were produced by PCR using different 5¢ and 3¢
primers and analyzed by PAGE. The results of the primer pairs
P2/T1, P2/T2, P2/T3, and P2/T4 are shown (see Methods section).
Note the differentially amplified cDNA fragments marked by (*).
Fig. 2. Cells that can be detached following colchicine treatment
bind preferentially to Shiga toxin, but bind again to Shiga and
Cholera toxin after desynchronization. (a) Vero cells detached from
the culture dish after colchicine treatment bind to Cy2-ST (upper left
panel). Cells remaining attached to the dish are larger, have an
extended structure (arrow) and bind only to Cy3-CTX (lower right
panel) but not Cy2-ST (lower left panel). DIC (differential
interference contrast) of the two lower panels. (b) Cells detached
after colchicine treatment were analyzed 30 minutes after detachment
for binding of Cy2-ST (upper left panel) and Cy3-CTX (upper right
panel). When detached cells were cultivated for another 12 hours,
they show again exclusive binding (arrows) of either Cy2-ST (lower
left panel) or Cy3-CTX (lower right panel) as seen in non-
synchronized cell cultures (compare with Fig. 1a).
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Cell cultures 
Vero, Vero 317 and PC 12 cells, mouse fetal astrocytes and
hippocampal neurons of newborn mice were cultivated in DMEM plus
10% FCS supplemented with 100 U/ml penicillin G and 0.1 mg/ml
streptomycin. PC12 cells were cultivated on collagen (Vitrogen) or
poly-L-lysine (Sigma) coated cover slips; hippocampal neurons were
cultured on a feeder layer of fetal mouse astrocytes. For the toxin
binding experiments, cells were transferred to DMEM without phenol
red, buffered with 10 mM Hepes.
Determination of cell cycle phases
S-phase cells were identified by the incorporation of BrdU. To this end,
Vero cells were incubated for 30 minutes under standard conditions in
the presence of 50-100 m M BrdU. Cells were washed with PBS, cooled
on ice and exposed to Cy-dye-labeled ST and CTX as below. Cells
were fixed with 4% paraformaldehyde and permeabilized with
0.1% saponin. Following blocking with PBS/0.1% fish gelatine, the
incorporation of BrdU into DNA was detected by immunofluorescence
using either a BrdU-specific monoclonal antibody (1/100) in
combination with Cy3- or Cy5-labeled rabbit-anti-mouse secondary
antibodies (1/200) or a FITC-conjugated monoclonal anti-BrdU
antibody (1/100). 
To identify cells in G2 or metaphase, the expression and
intracellular distribution of endogenous cyclin B1 was analysed by
immunofluorescence using a polyclonal rabbit anti-cyclin B1-antibody
or a mouse monoclonal anti-cyclin B1 antibody. For detection Cy-dye
labeled secondary antibodies were used. DNA was detected with DAPI
dissolved in Moviol.
Synchronization and cell cycle arrest
To obtain G0/G1 phase Vero cells, cells were maintained in 0.1% FCS
for 36 hours. After addition of serum within 8-10 hours, more than
30% of Vero cells were in G2 phase. For differentiation of PC12 cells
and neurons, 100 ng/ml NGF was added to the culture medium. 
For synchronization by a double-thymidine block the exponentially
growing Vero cells were arrested in G1 by treatment with thymidine
(3 mM) at 0.1% FCS. After 12 hours, cells were released from the
block by washing with PBS and addition of fresh medium (DMEM,
10% FCS). Cells were grown for another 10 hours and treated a second
time with 3 mM thymidine for 12 hours followed by release from the
block (as with the first block). Twelve hours after this release, 30-50%
of cells revealed a mitotic phenotype and nuclear staining for cyclin
B1. Binding of the toxins to the cell monolayer was analyzed 3, 6, 12,
and 24 hours after the release from the second thymidine block. 
Alternatively, cell monolayers were treated after 12 hours in culture
with 5 m g/ml colchicine for 2 or 3 hours. Detached cells were
sedimented by centrifugation (800 g for 5 minutes), washed with PBS
and exposed to Cy-dye-labeled toxins at 0°C while in suspension. The
cells were washed again and sedimented by centrifugation. An aliquot
of the sedimented cells was plated on a cover slip for fluorescence
microscopy. 
Fig. 3. Dividing cells bind only to Shiga toxin (Cy3-ST). Cells were
partially synchronized by a double-thymidine block and analyzed for
toxin binding 6 hours later. The relative number of small round-
shaped cells binding preferentially to Cy3-ST (upper left panel) is
significantly higher than in non-synchronized cultures. Note that the
dividing cells (arrows) bind only to ST. The flat, extended, irregularly
shaped cells bind only to Cy2-CTX (upper right panel). Lower left
panel: overlay of the two upper panels. Lower right panel: digital
interference contrast. 
Fig. 4. Cells in S-phase exhibt low binding of both toxins. Cells were
pretreated with BrdU, exposed to Cy2-CTX and Cy3-ST and
analyzed by fluorescence microscopy as in Fig. 1a. Cells were then
fixed, permeabilized and analyzed for BrdU incorporation using anti-
BrdU-antibodies. Cells strongly stained for BrdU (S-phase) show
little or no binding of CTX (CTX) or ST (ST). 
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Binding of Cy-labeled Shiga and Cholera toxin to cell surface
receptors
The binding conditions for Shiga and Cholera toxin were similar to
those described previously (Majoul et al., 1996). In short, cells were
exposed to 0.5 m g/ml each of CTX and/or ST at 0°C for 15 minutes.
Unbound toxins were removed by washing at 0°C. The temperature
was then increased to 25°C for 5 minutes. Immediately thereafter the
live cells were analyzed by fluorescence microscopy. In this way, toxin
binding as well as initial toxin uptake could be analyzed. 
Immunoblotting of cyclin B1 from FACS-separated Vero cells
Non-synchronized Vero cells were exposed to Cy-dye labeled ST and
CTX as described above. Cells separated by FACS as described below
were lysed on ice in lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl,
2 mM EDTA, 2 mM EGTA, 1% Triton X-100 with 2 m g/ml leupeptin,
2 m g/ml aprotinin, and 50 m M PMSF). Aliquots from the lysate were
heated for 5 minutes in Laemmli sample buffer, resolved by 12% SDS-
PAGE and electroblotted onto a PVDF membrane (ImmobilonTM). The
membranes were blocked in 2% dry milk in PBS and incubated with
a polyclonal rabbit anti-cyclin B1 antibody (1/1000) followed by
chemoluminescence detection with a horseradish-peroxidase-coupled
secondary antibody (ECL system, Amersham-Pharmacia, Freiburg).
Antibodies were removed by incubation in 0.1 M citric acid, pH 3.3.
The blot was then probed a second time with a rabbit anti-
protein disulfide isomerase antibody (1/500) and detected by
chemoluminescence using the same secondary horseradish-
peroxidase-labeled goat anti-rabbit antibody as above. 
Analyses of intracellular receptors for Cholera and Shiga toxin 
Non-synchronized Vero cells were incubated at 0°C with either Cy3-
ST or Cy5-CTX (0.5 m g/ml) for 20 minutes. Cells were washed at 0°C
to remove unbound toxins followed by fixation with 4%
paraformaldehyde for 10 minutes. Thereafter cells were exposed to
the same concentration of unlabeled toxins at 0°C for 5 minutes to
block the remaining toxin receptors on the cell surface; they were then
washed and fixed again with 4% paraformaldehyde for 5 minutes.
Remaining aldehyde groups were blocked with 50 mM NH4Cl. Cells
were then permeabilized with 0.1% (w/v) saponin in PBS/0.1% fish
gelatin and stained with Cy-3 or Cy5-labeled toxins for 20 minutes at
room temperature. Unbound toxins were removed by washing with
PBS, and cells were analyzed by fluorescence microscopy. 
Fluorescence and immunofluorescence microscopy and image
processing 
When binding and uptake of Cy-dye labeled toxins was analyzed in
live cells, the cells remained in phenol red free DMEM with 5-7%
FCS. Fluorescence microscopy was performed with a Zeiss Axioplan
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Fig. 5. Cells in G2 (cyclin B1 positive) and anaphase bind preferentially to Shiga toxin. (a,b) Non-synchronized Vero cells were exposed to
Cy2-ST and Cy3-CTX and analyzed by fluorescence microscopy as in Fig. 1a. Cells were then fixed, permeabilized and immunostained for
cyclin B1 (see Materals and Methods section). (a) and (b) represent different experiments of the same kind. Overlay represents the overlay of
CTX, ST and cyclin B1. (c) FACS-separated cells, binding either ST (lane 1) or CTX (lane 2) were extracted and identical amounts of proteins
separated by SDS-PAGE. Immunoblots were performed using anti-cyclin-B1- and anti-protein disulfide isomerase antibodies. Lane 3 represents
extracts from the same cells but before FACS separation. The amount of protein in lane 3 was about four times that applied in lanes 1 and 2. (d)
A cell in anaphase shows a significant binding and uptake of ST but not of CTX. Chromatin staining with DAPI. The cells were fixed about 10
minutes after start of uptake of the toxins. At this time point significant amounts of the toxins have already entered the cells. 
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microscope using 63· Plan Achromat and 100 · Neofluar objectives
and filters for excitation at l ex=488 nm for Cy2 fluoresence and
l ex=514 nm for Cy3 fluorescence. 
Fixed cells, as used during the analysis of cell cycle markers (see
above), were observed using a filter set for AMCA, FITC and Cy3.
Simultaneous detection of Cy2- and Cy3-labeled samples was
performed with a Zeiss LSM 410 laser scan microscope using laser
excitation at 488 nm and 514 nm respectively. Cy5 was detected and
laser excitation at 633 nm. 
Differential display of Cholera and Shiga toxin bound cells
Non-synchronized Vero cells were plated on 1.4 cm culture dishes as
described above. After 12 hours, cells were washed with PBS and the
dishes transferred to ice. Cells were treated for 20 minutes at 0°C with
Cy2-ST and Cy3-CTX (0.2 m g/ml each). Unbound toxins were
removed by washing with ice-cold PBS. Cells were then detached by
incubation with PBS containing 10 mM EDTA. Cy2- and Cy3-labeled
cells were separated using a BD FACSVantage SE flow cytometry
system (BD Biosciences), using filter settings for FITC and TRITC.
RNA was extracted from the separated cells according to
Chomczynski and Sacchi (Chomczynski and Sacchi, 1987) using the
peqGOLD RNA PureTM reagent and the protocol of the supplier
(Peqlab, Erlangen, Germany). cDNA was synthesized using oligo-
dT primers and MMLV reverse transcriptase (DeltaTM RNA
Fingerprinting Kit, Clontech, Heidelberg, Germany). For
amplification, ten 5¢ -primers (P1-P10) and nine 3¢ -primers (T1-T9)
were used (DeltaTM RNA Fingerprintin Kit, Clontech, Heidelberg,
Germany) together with Advantage Klen Taq polymerase in the
presence of [a -32P]-ATP. The first cycle was run for 5 minutes at
94°C, 40°C and 72°C; the following two cycles were run for 2 minutes
at 94°C and for 5 minutes each at 40°C and 72°C. This was followed
by 23 cycles run for 1 minute each at 94°C and 60°C and 2 minutes
at 72°C. The PCR products were separated by electrophoresis on
denaturing 5% polycrylamide gels. The gels were blotted onto
Whatman 1 paper, vacuum-dried and autoradiographed using Kodak
MR film. Differentially amplified cDNA-fragments were cut out
from the gel and reamplified under high stringency conditions with
the P/T-primer combination used for differential display. The
amplified fragments were cloned using the TOPOTM-TA cloning
kit (Invitrogen), amplified and sequenced. The possibility of
contamination by somatic DNA was excluded by comparing the band
patterns of non-transcribed RNA-samples with those of RNA-free
control samples; both gave identical results. Moreover, using the
method described, intron sequences were never detected. 
Results
Vero cells from a non-synchronized population can bind
to both Shiga and Cholera toxin
Non-synchronized cells can bind to both toxins (Fig. 1a).
However, a closer analysis of binding and internalization of the
two toxins on the single cell level revealed that the binding of
the two toxins by Vero cells exhibits a heterogeneous pattern.
Under steady-state conditions, some cells showed a weak
binding of both toxins, whereas most of the cells showed an
almost exclusive binding to either CTX or ST (Fig. 1a). 
Fig. 6. Vero cells that do not bind Shiga or Cholera toxin also lack
internal toxin receptors. (a) CTX-binding cells. The left panels (two
different experiments) show cells strongly binding Cy3-CTX to the
cell surface. The same cells also exhibit a strong binding of Cy5-
CTX to internal binding sites after permeabilization, whereas cells
that bind little Cy3-CTX to the surface lack internal binding sites for
Cy5-CTX. (b) (Upper panels) A cell that strongly binds to Cy2-ST
also expresses internal binding sites for Cy5-ST. (Lower panels) Two
cells that exhibit strong binding of Cy2-ST to the cell surface also
show internal receptors for Cy5-ST after cell permeabilization. Note
that surrounding cells that possess almost no internal binding sites
fail also to bind ST to the cell surface.
Fig. 7. Vero 317 cells in S-phase do not bind to Cholera toxin. The
experimental conditions used were the same as in Fig. 4. Cells bind
CTX (upper right panel) but not ST (upper left panel). Cells in S-
phase (BrdU) do not bind Cy3-CTX (lower left panel). Cy3-CTX-
binding cells do not incorporate BrdU. 
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Transcription is differently regulated in Shiga-toxin- and
Cholera-toxin-binding cells
Vero cells were incubated with Cy2-ST and Cy3-CTX and
separated by FACS. RNA from the separated cells was
extracted, reversed transcribed and analyzed by differential
display. The pattern of DNA fragments showed distinct
differences between ST- and CTX-binding cells (Fig. 1b).
Although the cDNAs corresponding to the RNA fragments
have not been identified yet, the different pattern shows clearly
that the differences between the two cell populations is not
restricted to their differential toxin binding. 
The different toxin binding patterns correspond to
different phases of the cell cycle 
When Vero cells were diluted to the single cell level and
recultivated to obtain clonal cells, again a mixture of ST- and
CTX-binding cells was obtained after 24-48 hours (data not
shown), which indicates that the different toxin binding
patterns did not represent genetically different cells but rather
different states of clonal cells. This led us to test the hypothesis
that the differences in the binding of the two toxins might
reflect different phases of the cell cycle. The following
experiments were carried out to test this hypothesis.
Cultured cells in metaphase bind weakly to cover slips and
can, therefore, be detached by colchicine treatment and
shaking, whereas cells in interphase or G1 remain on the glass
under the same condition. Therefore, Vero cells were treated
with colchicine as described in the Methods section, and
detached cells and cells that remained bound to the cover slip
were analyzed for ST- and CTX-binding. The detached and
replated cells had a round-shaped appearance and bound
exclusively to ST (Fig. 2a), whereas most of the cells
remaining on the cover slip were larger, flat and irregularly
shaped and bound only to CTX (Fig. 2a). Of 150 detached and
replated cells, all showed a strong binding of ST, whereas only
three of these cells exhibited a significant binding of CTX. On
the other hand, of the 50 large, flat, irregularly shaped cells that
had remained on the coverslip after colchicine treatment and
shaking, all bound strongly to CTX, and none of these cells
exhibited a significant binding of ST. When the detached cells,
which bound almost exclusively to ST, were reseeded, cultured
in the presence of serum for 12 hours and then analyzed for
toxin binding, the normal distribution between CTX- and ST-
binding cells was obtained (Fig. 2b). These results indicate that
Vero cells in interphase or G1 bind preferentially to CTX,
whereas cells in metaphase or anaphase bind mainly to ST.
To further substantiate this conclusion, Vero cells were
partially synchronized by a double thymidine block. Twelve
hours after release from the block, 30-50% of the cells were in
metaphase or anaphase (Fig. 3). These cells bound almost
exclusively to ST (Fig. 3, upper left panel), whereas cells in
interphase or G1, which were characterized by their strong
adhesion and their flat and extended appearence, bound only
to CTX (Fig. 3, upper right panel).
In order to obtain a more detailed picture, we correlated the
binding of the two toxins with the incorporation of BrdU on
one hand and the expression and intracellular distribution of
cyclin B1 on the other. Strong incorporation of BrdU is an
indicator of S-phase, whereas an increased expression and an
enhanced nuclear uptake of cyclin B1 is an indicator for G2
and metaphase (Kakino et al., 1996; Jin et al., 1998). As
depicted in Fig. 4, cells in S-phase exhibited only low binding
of both toxins, indicating that the expression of receptors for
both toxins on the cell surface strongly decreases during S-
phase. All of the 50 cells showing a strong incorporation of
BrDU exhibited either no or a very low binding to CTX and
ST. When the degree of toxin binding was quantified using a
7 degree scale (ranging from 1 equals no detectable binding to
7 equals very strong binding) the mean binding of CTX was
2.3±1.1 and the mean binding of ST was 2.2±1.3. As the
binding of CTX remained low through S-phase, G2, metaphase
and anaphase (see below) it is clear that some BrDU-negative
cells show a low degree of CTX-binding.
When cells move from S-phase into G2 and metaphase, the
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Fig. 8. PC12 cells also show cell-cycle-dependent expression of
receptors for CTX. (a-c) represent identical cells. No binding of Cy2-
ST is observed. Cy3-CTX binds almost exclusively to the large
peripheral cells; (c) differential interference contrast picture.
(d-g) NGF-differentiated cells show increased binding and uptake of
Cy3-CTX (d) and (f), whereas undifferentiated cells characterized by
their round shape and lack of axonal protrusions (small arrows in (d)
and (e)) show little CTX-binding. (h) and (i) PC12 cells in S-phase
as characterized by BrdU incorporation (i) do not bind CTX (h).
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expression of cyclin B1 increases together with an enhanced
translocation into the nucleus (Fig. 5a,b). This shift was
associated with an increase in the binding of ST, whereas the
binding of CTX remained as low as during S-phase (Fig. 5a,b).
Out of the 60 cells that gave a strong nuclear signal for cyclin
B1, all showed a strong binding of ST, whereas binding of CTX
to these cells was either undetectable or very low. Those cells
in which significant amounts of cyclin B1 were detected in the
nucleus, showed a very strong binding of ST. This was further
substantiated by estimating the amount of cyclin B1 from
immunoblots from ST- and CTX-positive cells after their
separation by FACS (Fig. 5c). Clearly, the cells preferentially
binding to ST expressed significantly more cyclin B1 than the
CTX-positive cells. 
In summary, we find that cells in interphase and G1 bind
almost exclusively to CT. Cells in S-phase exhibit a decreased
binding of both toxins, whereas the transition from S-phase to
the G2, metaphase and anaphase is associated with a loss of
binding of CTX and an increased binding of ST (Fig. 5d). Upon
transition into G1, binding of CTX reappears, whereas the
ability of the cells to bind to ST decreases or disappears.
Decreased toxin binding results from decreased
receptor biosynthesis
As binding of the two toxins to the plasma membrane is
determined by the density of receptor molecules in the
membrane, we conclude that the cell-cycle-dependent
differential binding of the two toxins reflects cell-cycle-
dependent expression of GM1 and Gb3 on the plasma
membrane. This could result from reduced or absent synthesis
of toxin receptors or from a block of receptor transport from the
place of synthesis to the plasma membrane. Therefore, we
analyzed the expression of intracellular receptors in
permeabilized Vero cells. Unpermeabilized cells showing strong
binding to CTX also exhibited significant binding of this toxin
to intracellular sites (Fig. 6a). The same holds for cells showing
strong surface binding of ST. Cells that exhibited no or little
binding of either toxin to the cell surface were also devoid of
intracellular toxin binding sites for the corresponding toxin after
cell permeabilization (Fig. 6a,b). This allows for the conclusion
that changes in the binding of either toxin results from the
corresponding changes in synthesis of the glycolipid receptors. 
Cell-cycle-dependent binding of Cholera toxin to Vero
317 cells
Both the ganglioside GM1 and the globoside Gb3 are
synthesized from the same precursor, namely lactosyl
Fig. 9. Differential binding of Cy2-labeled Shiga toxin and Cy3-
labeled Cholera toxin to fetal mouse astrocytes and binding of Cy3-
labeled CTX to hippocampal neurons. (a) Binding of Cy3-CTX to
astrocytes. Binding conditions were the same as in Fig. 1a. During
inspection of the live cells under the fluorescence microscope, some
CTX is taken up and accumulates in the Golgi. (b,c) Astrocytes that
exhibit significant BrdU incoporation (blue-white nuclei in (c)) show
only weak binding of ST (b) or CTX (c). (d,e) Binding and uptake of
Cy3-CTX by hippocampal neurons. All axons and dendrites exhibit a
strong binding of the toxin. In (e), several neuronal cells on top of a
Cy3-CTX-binding astrocyte are depicted.
Fig. 10. A schematic presentation of cell-cycle-dependent differential
synthesis of receptors for Cholera and Shiga toxin.
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ceramide. We, therefore, explored the possibility that an
increased synthesis of Gb3 from lactosylceramide during late
G2 and M-phase might have competed for the synthesis of
GM3 or GA2, precursors of GM1 (Fig. 10). This hypothesis
was tested in Vero 317 cells, which are unable to bind ST
(Pudymaitis et al., 1991) while still binding CTX (Fig. 7). As
these cells also show a decreased or absent binding of ST after
permeabilization of the cells in comparison to normal Vero
cells (data not shown), the decreased surface binding of ST by
Vero 317 cells indicates not simply a disturbed translocation of
Gb3 to the plasma membrane but a decreased synthesis of Gb3.
Therefore, if the decreased binding of CTX during S-phase, G2
and M-phase in normal Vero cells results from a competition
for lactosylceramide owing to increased Gb3 synthesis, such a
decrease should not occur in Vero 317 cells. We analyzed,
therefore, the cell-cycle-dependent binding of CTX in Vero
317 cells.
Similar to normal Vero cells, Vero 317 cells show CTX
binding in flat, extended cells of the G0/G1-type (Fig. 7). Vero
317 cells in S-phase, which are characterized by a high
incorporation of BrdU, bound little or no CTX (Fig. 7). From
this we conclude that the cell-cycle-dependent changes in
expression of the CTX-receptor GM1 on the cell surface
does not result from a cell-cycle-dependent competition for
lactosylceramide. This conclusion is supported by data
obtained from PC12 cells and from astrocytes (see below). 
Cell-cycle-dependent binding of CTX to PC12 cells,
primary cultured hippocampal neurons and astrocytes
We next addressed the question of whether the cell-cycle-
dependent expression of toxin receptors is restricted to Vero
and Vero 317 cells or whether it occurs also in completely
different cell types. 
To this end, we performed experiments with PC12 cells, a
neuro-endocrine cell line. PC12 cells bind CTX but not ST
(Fig. 8a,c). But not all PC12 cells showed strong CTX binding;
many cells exhibited weak or no CTX binding. In particular
PC12 cells in S-phase, as indicated by a high incorporation of
BrdU, did not bind CTX (Fig. 8h,i). In order to achieve some
kind of synchronization, we treated PC12 cells with NGF, as
this growth factor is known to induce cellular differentiation
and arrest of the cells in G0/G1 (Hughes et al., 2000). Indeed,
all cells showing signs of differentiation (flat, extended shape,
development of axonal protrusion or axons) bound CTX (Fig.
8d,g). This indicates that in PC12 cells, CTX binding is
regulated by the cell cycle in a similar way as in Vero and Vero
317 cells. This conclusion was further supported by our
observation that primary cultured hippocampal neuronal cells,
which exist only in interphase, uniformly exhibited a strong
binding to CTX (Fig. 9d,e).
As the hippocampal neuronal cells were cultivated on top of
a feeder layer of astrocytes, we have also explored the binding
of the two toxins to these cells. Astrocytes bound ST as well
as CTX, but, similar to Vero cells, cells exhibiting a strong
binding of ST did not bind CTX and vice versa (Fig. 9a,c).
Furthermore, astrocytes in S-phase, as indicated by a strong
incorporation of BrdU, showed little binding of both toxins
(Fig. 9b,c). Thus, astrocytes show the same cell-cycle-
dependent differential expression of receptors for ST and CTX
as Vero cells. 
Discussion
We show here that glycosphingolipid receptors specific for two
different AB5 toxins exhibit cell-cycle-dependent changes in
their expression on the cell surface. The expression of the ST
receptor globotriaoside Gb3 is low during interphase and G1,
as well as during S-phase. It strongly increases during G2 and
metaphase. In contrast, the highest expression of the CTX
receptor GM1 takes place during interphase and G1, decreases
during S-phase and stays low during G2, metaphase and
telophase. One practical aspect of these results is that they offer
a fast and straightforward method for assessing cell-cycle
phases at the single cell level in non-synchronized cells. 
A decreased expression of these glycolipids on the cell
surface could reflect either their decreased net synthesis or an
inhibition of their translocation from the Golgi to the plasma
membrane. An enhanced degradation of the glycolipids or their
increased endocytosis could also be responsible. We observed
that cells that did not bind ST or CTX on the outer plasma
membrane had also lost the corresponding binding sites inside
the cell. This argues strongly for an increased net synthesis of
Gb3 or GM1 in cells exhibiting an increased binding of ST or
CTX, respectively. Using verotoxin, a Shiga-like toxin, in
experiments with Vero cells, Pudymaitis and Lingwood
(Pudymaitis and Lingwood, 1992) observed a maximum
toxicity at the G1/S-phase boundary but could not detect
changes in the cellular Gb3 content or in the incorporation of
[14C]-galactose into Gb3. In these experiments, the whole
population of cultured cells was analyzed at different time
points after a double-thymidine block. Thus, a correlation
between surface expression of Gb3 and parameters of the cell
cycle could not be examined at the single cell level. It is our
experience that Vero cells after a double-thymidine block start
within a few hours to desynchronize. Therefore, the cell-cycle-
dependent expression of Gb3 and GM1 can be reliably
correlated only by analyzing single cells. Interestingly
Pudymaitis et al. (Pudymaitis et al., 1991) observed that in
verotoxin-resistant Vero cells the decreased toxin binding was
paralleled by a decreased cellular Gb3 content and a strong
reduction of the activity of UDP-galactose:lactosylceramide-
a -galactosyltransferase, which converts lactosylceramide into
Gb3 (Kojima et al., 2000; Keusch et al., 2000). As we found
here an inverse relationship between the binding of CTX and
that of ST we considered the possibility that the biosynthetic
reactions leading to GM1 and Gb3 respectively might compete
for the common precursor lactosylceramide and that a cell-
cycle-dependent change in the activity of a -galactosyl-
transferase-activity might be responsible for the observed
changes. However, as shown here by the experiments with the
ST-resistant Vero317-cell line, the cell-cycle-dependent
changes in the expression of GM1 on the cell surface occurred
in the same way as in normal, ST-sensitive cells. These data
were confirmed by our experiments with PC12 cells.
At the moment we can only speculate on the biochemical
mechanism underlying the cell-cycle-dependent expression of
GM1 on one hand and Gb3 on the other. These mechanisms
must act downstream of the synthesis of lactosylceramide as
this metabolite is a common precursor for both types of
glycosphingolipids. Synthesis of Gb3 may then be regulated
by the cell-cycle-dependent expression of the highly specific
a -galactosyltransferase (Kojima et al., 2000; Keusch et al.,
2000). 
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The biosynthesis of GM1 may involve several steps. An
UDP-N-acetyl-galactosyl transferase converts lactosylceramide
to GA2, and GM3 to GM2, both precursors of the CTX-
receptor GM1. It has been reported in a hybrid rat glioma-
neuroblastoma cell line, that the activity of this enzyme reaches
a maximum during S- and G2-phase (Scheideler et al., 1984).
This is not in line with our observation that the expression of
CTX receptors on the cell surface reaches a minimum during
S- and G2-phase.
Another possibility would be a cell-cycle-dependent
regulation of sialyltransferase I, which catalyzes the conversion
of lactosylceramide to GM3, and of GA2 to GA1, both
precursors for GM1. The activity of this enzyme reaches its
maximum during telophase and G1 and is elevated in contact-
inhibited cultured cells (Burczak et al., 1984). Another
mechanism has also to be considered, namely regulation by
breakdown. Scheideler et al. (Scheideler et al., 1984) observed,
in a synchronized hybrid rat glioma-neuroblastoma cell line, a
strong increase in the activities of N-acetyl-b -hexosaminidase
and of b -galactosidase 18-20 hours after release of the cells
from a block in G1. This would fit our observation of a very
low binding of CTX in S- and G2-phase. As the activities of
the glycospingolipid-degrading enzymes undergo a complex
regulation by sphingolipid activator proteins (SAP-A to SAP-
D and the GM2 activator) (for a review, see Fürst and Sandhoff,
1992) it seems possible that these regulatory proteins may also
be involved in regulating the net amount of the AB5 receptors
and their expression on the cell surface.
The question is does cell-cycle-dependent expression of Gb3
and GM1 represent an epiphenomenon or does it play a
regulatory role in the progression of the cell cycle.
Physiological ligands for Gb3 or GM1 have not been reported
so far. However, effects of glycosphingolipids on growth-
related processes have been described. In bovine aortic
endothelial cells GM1 or GM2 inhibit bFGF-induced
mitogenesis by interfering with bFGF binding, whereas GM3
is synergistic with bFGF (Slevin et al., 1999). In T-
lymphocytes gangliosides inhibit the interaction of IL-2 with
its plasma membrane receptor, which was explained by a direct
interaction of IL-2 with the gangliosides (Chu et al., 1993). In
the fetal cell lines, CH I and CH II gangliosides inhibit [3H]-
thymidine incorporation into DNA (Icard-Liepkalns et al.,
1982). In keratinocytes, GM3, but not GM1 or GD1a,
stimulates proliferation (Paller et al., 1993), which contrasts
with the situation in K562 leukemia cells, where GM3 inhibits
growth, while GM1, GM2 or GD1a have no effect (Nakamura
et al., 1991). In lung adenocarcinoma cells, GM3 inhibits the
proliferative action of EGF, most probably by activation of a
EGF-receptor-directed phosphotyrosine phosphatase (Suarez
Pestana et al., 1997). Inhibition by gangliosides of T-cell
proliferation seems also to result from the activation of a
protein phosphatase, in this case resulting in a diminished
phosphorylation of the retinoblastoma protein (Irani, 1998). In
PC12 cells, GM1 potentiates the action of NGF by tight
binding to the NGF receptor, thus enhancing its tyrosine kinase
activity and dimerization (Mutoh et al., 1995). In the absence
of NGF, GM1 did not have any effect. On the other hand, the
mere overexpression of GD3, GD1b and GT1b induced
dimerization and a long-lasting activation of the NGF-receptor
TrkA with subsequent activation of the Ras/MEK/ERK
pathway (Fukumoto et al., 2000). Under these conditions the
sensitivity towards NGF was lost but could be restored by the
addition of GM1 (Mutoh et al., 1995). 
It thus appears that glycosphingolipids are involved in the
tuning of complex processes like growth and differentiation,
which are tightly linked to cell cycle activity. Further progress
will require a knowledge of the physiological ligands for the
glycosphingolipid receptors on the plasma membrane. 
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